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Abstract Mox1 and Mox2 homeobox genes have been shown to
be critical in axial skeleton and in limb muscle development
respectively. Pax1 and Pax3 gene products are also implicated in
these processes. Mox and Pax expression patterns are highly
overlapping both spatially and temporally during embryonic
development. We show here for the first time that Mox proteins
physically interact with Pax1 and Pax3 using the yeast two-
hybrid protein interaction assay as well as in vitro biochemical
assays. There is a strong preference of Mox1 to associate with
Pax1 rather than Pax3 and of Mox2 to associate with Pax3
rather than Pax1. The observed interactions are mediated
through the homeodomain of Mox. ß 2001 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
Homeoproteins have been recognized as critical regulators
of morphogenetic processes [1]. The development of the axial
skeleton and musculature require the concerted function of
various homeoproteins and other factors. The Mox genes ^
Mox1 and Mox2 ^ constitute a subfamily of non-clustered,
diverged, antennapedia-like homeobox-containing genes
which are expressed in a wide range of mesodermal structures
[2^5]. Mice homozygous for a null mutation in the Mox1
locus have vertebral abnormalities manifested mainly as
hemi-vertebrae, tail kinks and craniovertebral fusions (B.S.
Mankoo and V. Pachnis, unpublished observations). On the
other hand, mice homozygous for a null mutation of Mox2
have a developmental defect in the limb musculature, charac-
terized by an overall reduction in muscle mass and elimination
of speci¢c muscles. Mox2 is essential for the normal regula-
tion of myogenic genes in limb myoblasts, as demonstrated by
the down-regulation of Pax3 and Myf5 in Mox2-de¢cient limb
buds [6]. Rat Mox2 (Gax) is implicated in myocyte growth
arrest [7,8], while chick Mox2 is associated with non-prolifer-
ating myoblasts in the limb (Rallis et al., in press).
Another family of transcription factors, the Pax genes, have
been shown to participate in various developmental processes.
The Pax genes ^ Pax1 to Pax9 ^ are characterized by the
presence of the paired domain, a conserved amino acid motif
with DNA binding activity [9]. Pax1 is expressed in the scle-
rotome and plays an important role during axial skeletal de-
velopment [10]. Homozygous mutant mice of a de¢ned Pax1
null allele exhibit morphological abnormalities of vertebrae
and intervertebral disks [11]. In the absence of Pax1 and
Pax9, which is also expressed in the sclerotome, the scleroto-
mal cell population is reduced by a decrease in cell prolifer-
ation, followed by an abnormally high rate of apoptosis that
later contributes to the substantial loss of sclerotome size [12].
Pax3 is expressed in the dermomyotome and has been
shown to function upstream of MyoD during skeletal myo-
genesis [13^15]. Mice carrying a null mutation for Pax3
(splotch mutants) show severe defects in skeletal muscle devel-
opment [16]. In myoblast cultures, Pax3 induces cell prolifer-
ation and inhibits di¡erentiation while in limb buds, Pax3 is
associated with proliferating myoblasts [17,18].
Mox genes and members of the Pax gene family are impli-
cated in common developmental processes as mentioned
above. Their expression patterns are highly overlapping both
spatially and temporally during embryonic development.
Mox1 and Mox2 are highly expressed in the developing so-
mites, especially in the sclerotome where they are co-expressed
with Pax1. Mox2 and Pax3 are also expressed in migrating
myoblasts ([6,13,18], Rallis et al., in press). We decided to test
the hypothesis that Mox proteins physically interact with
Pax1 and Pax3. Interactions of the Mox with the Pax family
are shown for the ¢rst time in this report, both by the yeast
two-hybrid protein interaction assay and by in vitro biochem-
ical assays. The physiological implications of these interac-
tions are discussed.
2. Materials and methods
2.1. In vitro interactions
Full-length Mox1 and Mox2 and their deletions (Fig. 2) were
cloned in the pGEX vector (Amersham) in frame with glutathione
S-transferase (GST), then produced in Escherichia coli and puri¢ed
on glutathione Sepharose beads according to [19]. The Pax3 deletion
construct Pax3dC encodes amino acids 1^230 and Pax3dHD encodes
amino acids 1^306 out of 479 amino acids of the full-length protein.
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Full-length Pax1 and Pax3 were cloned in the pCMX-Flag vector [20]
in frame with the Flag epitope. Transient transfections of COS1 cells
were performed using the calcium phosphate method according to
[21]. Forty hours post-transfection of COS1 cells, total extracts were
prepared by lysing the cells in 20 mM Tris^HCl, pH 7.5, 150 mM
NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 1 mM phenylmeth-
ylsulfonyl £uoride (PMSF), 2 Wg/ml aprotinin at 4‡C. The cell extracts
were clari¢ed from the insoluble material by 30 min centrifugation at
10 000 rpm and were precleared by incubation with glutathione Se-
pharose beads at 4‡C for 1 h. GST fusion proteins loaded on gluta-
thione Sepharose beads were incubated in the presence of the pre-
cleared cell extracts for 3 h at 4‡C, then washed ¢ve times with lysis
bu¡er. Samples were boiled for 5 min in Laemmli sample bu¡er and
electrophoresed on 10% SDS polyacrylamide gel. Western blot anal-
ysis was performed as described in [22] except the bands were devel-
oped with the ECL detection kit (Amersham). The anti-Flag M2 anti-
body (Sigma) was used to detect Flag-Pax1 and Flag-Pax3. Whenever
35S-labeled proteins were used they were prepared with the TNT sys-
tem (Promega) according to the manufacturer’s instructions. Gluta-
thione Sepharose beads loaded with GST fusion proteins were equil-
ibrated in washing bu¡er (150 mM KCl, 20 mM HEPES pH 7.9,
5 mM MgCl2, 0.1% Nonidet-P40, 1 mM PMSF, 1 mM dithiothreitol).
Then they were combined with 2 Wl 35S-labeled reticulocyte lysate in a
¢nal volume of 200 Wl of washing bu¡er, 0.2% (w/v) bovine serum
albumin (interaction bu¡er) on a rotator for 4 h at 4‡C. The beads
were then washed ¢ve times with washing bu¡er, the bound proteins
were eluted by boiling in Laemmli sample bu¡er and subjected to
SDS^PAGE. Bound proteins were visualized by autoradiography.
2.2. Yeast two-hybrid assay
Bait plasmids were constructed by cloning the Pax1 (from the 230th
nucleotide of its coding sequence, that is from the third helix of the
paired domain, to the stop codon) and Pax3 full-length coding se-
quences in frame with the GAL4 DNA binding domain of the
pAS1-CYH2 cloning vector (Clontech). Prey plasmids were con-
structed by cloning Mox1 and Mox2 coding sequences (full-length
and deletions; Fig. 1) in frame with the VP16 transactivation domain
of the pVP16 cloning vector described in [23].
Yeast strain Y187 was used and the genotype is MATK, ura3-52,
his3-200, ade2-101, trp1-901, leu2-3, 112, gal4v, met3, gal80v,
URA3: :GAL1UAS-GAL1TATA-lacZ [24]. Standard synthetic media
were used; YPD medium contained 2% glucose. SD minimal medium
contained glucose as carbon source and a dropout solution that con-
tains essential nutrients (amino acids and nucleotides) was used in
yeast transformations to select for speci¢c phenotypes. Standard pro-
cedure was used for yeast transformations.
2.3. LacZ assays
L-Galactosidase assays were performed on yeast cultures grown in
the appropriate media and harvested during early log phase
(A6006 1.0). LacZ values (A420) were normalized to A600. Each plus
(+) in Tables 1 and 2 represents L-galactosidase activity three-fold
over the corresponding negative control (Pax1^VP16 or Pax3^
VP16). Estimations were based on at least three independent trans-
formants.
3. Results
3.1. Mox associate with Pax in the two-hybrid assay
We investigated whether Mox1 and Mox2 proteins interact
with proteins of the Pax family, namely Pax1 and Pax3, using
the two-hybrid assay. Full-length Mox proteins and their de-
letions used in this assay are shown in Fig. 1. L-Galactosidase
activity is presented in Tables 1 and 2 (see also Section 2). We
observed that Pax1 interacted with Mox1 and weakly with
Mox2. In addition, the Mox deletions containing the homeo-
domain, CMox1 and CMox2, interacted with Pax1. The in-
teractions of Pax1 with the Mox shown here were independent
of the N-terminal 76 amino acids of Pax1 (see Section 2). A
strong interaction was observed between Pax3 and Mox2,
while Pax3 and Mox1 interacted weakly. The Mox deletion
derivatives containing the homeodomain, CMox1 and
CMox2, also interacted with Pax3. Given these observed in-
teractions we further investigated whether these proteins asso-
ciate in vitro.
3.2. Mox1^Pax1 and Mox2^Pax3 interact in vitro
To test whether Mox1 and Pax1 as well as Mox2 and Pax3
associate in vitro we expressed these proteins and their dele-
Fig. 1. Diagram of Mox1 and Mox2 proteins and their deletions
used for the two-hybrid assay. Proteins were fused with the VP16
transactivation domain in their N-termini. Numbers refer to amino
acids present in Mox proteins.
Table 1
Interactions between Pax1, Mox1 and Mox2 in the two-hybrid as-
say
Partnersa Bindingb
Pax1^VP16 3
Pax1^Mox1 +++
Pax1^NMox1 3
Pax1^CMox1 +++
Pax1^Mox2 +
Pax1^NMox2 3
Pax1^CMox2 +++
aMox1 and Mox2 constructs were in fusion with the VP16 transacti-
vation domain, the Pax1 and Pax3 constructs were in fusion with
the GAL4 DNA binding domain. See Fig. 1 for diagram of Mox
protein and deletions.
bBinding was estimated by measuring L-galactosidase activity in liq-
uid cultures (see Section 2).
Table 2
Interactions between Pax3, Mox1 and Mox2 in the two-hybrid as-
say
Partnersa Bindingb
Pax3^VP16 3
Pax3^Mox1 +
Pax3^NMox1 3
Pax3^CMox1 +++
Pax3^Mox2 +++
Pax3^NMox2 3
Pax3^CMox2 +++
aMox1 and Mox2 constructs were in fusion with the VP16 transacti-
vation domain, the Pax1 and Pax3 constructs were in fusion with
the GAL4 DNA binding domain. See Fig. 1 for diagram of Mox
protein and deletions
bBinding was estimated by measuring L-galactosidase activity in liq-
uid cultures (see Section 2).
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tions in bacteria and tested them in biochemical assays. In
parallel, we attempted to coimmunoprecipitate Mox2 and
Pax3 in cell extracts from developing tissues. As these experi-
ments failed, probably due to limiting amounts of Mox2 pro-
tein and/or the sensitivity of available reagents, we proceeded
with the in vitro approach.
Recombinant full-length Mox1 and Mox2 proteins fused to
GST were expressed in E. coli. Flag epitope-tagged Pax1 and
Pax3 proteins were expressed in COS1 cells transfected with
the respective plasmids. GSTMox1 and GSTMox2 fusion pro-
teins were puri¢ed on glutathione Sepharose beads and then
incubated with cell extracts of COS1 expressing FlagPax1 and
FlagPax3 respectively. The interaction was detected with
Western blot analysis using monoclonal anti-Flag antibody
after SDS^PAGE of the proteins retained on the glutathione
beads. As a negative control we used glutathione Sepharose
beads loaded with GST alone as well as cell extracts from
COS1 cells transfected with a control plasmid. Pax1 interacted
with Mox1 (Fig. 3A) and Pax3 with Mox2 (Fig. 4A) in the in
vitro interaction assay, in agreement to the two-hybrid assay
results.
Fig. 3. Pax1 interacts with Mox1 and Mox2 in vitro. A: GST inter-
action assays were performed using GST, GSTMox1 (4 Wg) and cell
lysates prepared from COS1 cells transfected with a control plasmid
or one expressing Flag-tagged Pax1. Immobilized proteins (arrow)
were resolved by SDS^PAGE and visualized by Western blot analy-
sis using an anti-Flag antibody. Input, 1% of the input protein ex-
tract. In A, dashes indicate molecular mass markers: 81, 49.9, 36.2
kDa. B: Pax1 interacts with Mox1 and Mox2 through the Mox ho-
meodomain. GST interaction assays were performed with 4 Wg
GST, GSTMox1, GSTMox2 and their N- and C-terminal deletions
(see Fig. 2 for diagrams) and 35S-labeled Pax1. Immobilized proteins
(arrow) were resolved by SDS^PAGE and visualized by autoradiog-
raphy. Input, 20% (1 Wl) of 35S-labeled Pax1.
Fig. 4. Pax3 interacts with Mox1 and Mox2 in vitro. A: GST inter-
action assays were performed using GST or GSTMox2 (4 Wg) and
cell lysates prepared from COS1 cells transfected with a control
plasmid or one expressing Flag-tagged Pax1. Immobilized proteins
(arrow) were resolved by SDS^PAGE and visualized by Western
blot analysis using an anti-Flag antibody. Input, 1% of the input
protein extract. In A, dashes indicate molecular mass markers: 81,
49.9 kDa. B: Pax3 interacts with Mox1 and Mox2 through the
Mox homeodomain. GST interaction assays were performed with
4 Wg GST, GSTMox1, GSTMox2 and their N- and C-terminal dele-
tions (see Fig. 2 for diagrams) and 35S-labeled Pax3. Immobilized
proteins (arrow) were resolved by SDS^PAGE and visualized by
autoradiography. Input, 20% (1 Wl) of 35S-labeled Pax3.
Fig. 2. Diagram of GSTMox1 and GSTMox2 proteins and their de-
letions used for the in vitro interaction assays. Proteins were fused
with GST in their N-termini. Numbers refer to amino acids present
in Mox proteins.
FEBS 24972 14-6-01
D. Stamataki et al./FEBS Letters 499 (2001) 274^278276
3.3. Interaction between Mox and Pax is mediated by the
homeodomain of the Mox proteins
To map the regions of Mox1 and Mox2 required for the
interaction with Pax1 and Pax3 respectively, we performed
GST interaction assays using 35S-labeled Pax1 and Pax3 and
a series of truncated GSTMox1 and GSTMox2 proteins (Fig.
2). We found that 35S-labeled Pax1 and Pax3 interacted only
with the full-length Mox1 and Mox2 and with their C-termi-
nal deletions that contain the homeodomain (Figs. 3B and
4B). Furthermore, in the same assay, GSTMox1 does not
interact with 35S-labeled Mox2 (data not shown), pointing
to the speci¢city of the Mox^Pax interaction through the
Mox homeodomains and not any homeodomain in general.
3.4. Pax3 homeodomain is necessary for the interaction with
Mox2
To map the regions of Pax3 required for its interaction with
Mox2 we generated a series of Pax3 truncated polypeptides
(Fig. 5B) and tested their interaction with GSTMox2. We
found that Pax3 and Pax3dC, both of which contain the ho-
meodomain, interacted with GSTMox2 (Fig. 5A), whereas no
such interaction was detected between GSTMox2 and
Pax3dHD (Fig. 5A) or a shorter (amino acids 1^187) Pax3
deletion (data not shown).
4. Discussion
In this study we aimed to investigate whether Mox family
proteins physically interact with Pax1 and Pax3. Indeed, such
interactions were revealed using the yeast two-hybrid and in
vitro biochemical assays. We show that Mox1 and Mox2 pro-
teins are capable of interacting with Pax1 and Pax3. There is a
strong preference of Mox1 to interact with Pax1 rather than
Pax3 and of Mox2 to interact with Pax3 rather than Pax1
(Tables 1 and 2, Fig. 6). These interactions are mediated
through the homeodomain of Mox. The weak interactions
of both Mox1 protein with Pax3 and Mox2 with Pax1 could
be due to the high degree of similarity between the Mox1 and
Mox2 homeodomains (98%). The speci¢city of interactions is
therefore determined by a di¡erent region of the Mox pro-
teins. In the case of the Mox1^Pax1 pair, our two-hybrid
results do not implicate the ¢rst two helices of the paired
domain of Pax1 (which are necessary for its DNA binding
activity) in the interaction with Mox1. In the case of the
Mox2^Pax3 pair, the homeodomain of Pax3 is necessary for
the interaction to occur. Interestingly, the paired domain of
Pax3 has been shown to associate directly with the homeodo-
main protein Msx1, which antagonizes the myogenic activity
of Pax3 in migrating limb muscle precursors so that prema-
ture di¡erentiation is avoided [25].
These data were con¢rmed in two independent assays and
are supported by in vivo expression data. The spatiotemporal
expression patterns of the genes/proteins are highly overlap-
ping. In particular, Mox1 is expressed in the sclerotome and
dermomyotome of the developing somite; Mox2 is expressed
in the sclerotome, in the migrating myoblasts that colonize the
limbs and the premuscle mass of the limbs [2,5,6]. Pax1 is
expressed in the sclerotome [10], Pax3 in the dermomyotome,
the migrating myoblasts and the premuscle masses that will
give rise to the limb musculature [13]. The expression patterns
of the genes are consistent with the possibility of physical
association of the gene products in vivo. The phenotypes of
mutant mice are also consistent with this possibility although
the observed defects (at least in the case of Pax3) are more
widespread. Mox1 and Pax1 mutants have malformations in
the axial skeleton, while Mox2 and Pax3 mutants show de-
fects in the limb musculature. Considering the preference of
Mox1 to interact with Pax1 and of Mox2 to interact with
Pax3, the expression patterns and phenotypes of mutant
mice, we hypothesize that only the Mox1^Pax1 and Mox2^
Pax3 interactions occur in the developing embryo.
Mox-interacting proteins have not been identi¢ed up to
now. Given the importance of Mox1 and Mox2 in the devel-
opment of axial skeleton and limb musculature respectively,
this information provides further insight into how these pro-
cesses may be regulated. Mox2 and Pax3 are both implicated
in the regulation of myoblast proliferation. Rat Mox2 (Gax)
is implicated in growth arrest of myocardium and vascular
smooth muscle cells [7,8] and chicken Mox2 is associated
with non-proliferating skeletal myoblasts in the limb (Rallis
et al., in press). On the other hand, Pax3 induces cell prolif-
eration and inhibits di¡erentiation in skeletal myoblast cul-
tures [17]; and in the limb bud, Pax3 is associated with pro-
liferating myoblasts [18]. It is possible that protein^protein
interactions between Mox2 and Pax3 exist mainly in the my-
oblasts that colonize the limb; these interactions may be as-
sociated with the regulation of myoblast proliferation during
their migration from the somite to the limb bud.
At present, there are no indications as to what the function
of Mox1 may be at the cellular level. Its interacting partner,
Fig. 5. Pax3 homeodomain is necessary for interaction with
GSTMox2. A: Interaction assays were performed using 4 Wg GST
or GSTMox2 and 2 Wl of the indicated 35S-labeled Pax3 polypep-
tides. Input, 50% (1 Wl) of 35S-labeled Pax3 polypeptides. Dashes in-
dicate molecular mass markers: 81, 49.9, 36.2, 29.9 kDa. B: Pax3
and its deletions (Pax3dC^Pax3dHD) with the paired domain, ho-
meodomain and octapeptide (gray box) indicated.
Fig. 6. A model for Mox^Pax protein^protein interactions. The
thick arrows point to the preferred interactions while the thin ones
point to weaker interactions.
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Pax1 (as well as Pax9 which is thought to be redundant in
function), is required to maintain a high rate of cell prolifer-
ation during a restricted phase of sclerotome development
[12]. It would be interesting to investigate how the direct in-
teraction of Mox1 with Pax1 may in£uence sclerotomal devel-
opment. It should be noted that Pax1, unlike Pax3, does not
possess a homeodomain, therefore it is not possible to make a
direct comparison between Mox1^Pax1 and Mox2^Pax3 in-
teractions.
Di¡erent gene families are involved in the control of the
assignment of somite cells to their myogenic, chondrogenic
and other lineages as well as in the regulation of the balance
between proliferation, apoptosis and di¡erentiation. The evi-
dence presented here points to speci¢c associations of Mox
and Pax proteins. We propose that the Mox family of homeo-
domain proteins participates in the molecular signaling net-
work regulating the diverse events of somite development
through the physical interaction with the Pax1 and Pax3
members of the Pax family.
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